CPB2, carboxypeptidase B2, 1361

N. diseases: 148; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0398623
Disease: Thrombophilia
Thrombophilia
0.050 Biomarker disease BEFREE The authors discuss the similarities and differences between TIC and MAC, and propose a mechanism for the hypercoagulable state of MAC that revolves around the thrombomodulin-thrombin complex as it switches between activating the protein C anticoagulation pathway or the thrombin activatable fibrinolysis inhibitor coagulation pathway. 31108555 2019
CUI: C0398623
Disease: Thrombophilia
Thrombophilia
0.050 AlteredExpression disease BEFREE TAFI serves as a link between two limbs of hemostasis, with its higher levels promoting inhibition of fibrinolytic system and thus promoting a hypercoagulable state. 27487812 2017
CUI: C0398623
Disease: Thrombophilia
Thrombophilia
0.050 AlteredExpression disease BEFREE High level of TAFI antigen in attack-free period of FMF disease shows ongoing subclinical inflammation and hypercoagulability. 24580410 2014
CUI: C0398623
Disease: Thrombophilia
Thrombophilia
0.050 Biomarker disease BEFREE Thrombin-activatable fibrinolysis inhibitor (TAFI) may contribute to a hypercoagulable state, and therefore we were interested in the role of TAFI in SVT. 17264944 2007
CUI: C0398623
Disease: Thrombophilia
Thrombophilia
0.050 GeneticVariation disease BEFREE Polymorphisms in the TAFI promoter determine plasma antigen levels and may influence the risk of venous thrombophilia. 11410415 2001